208 related articles for article (PubMed ID: 4826498)
1. Planning combined therapy--the interaction of experimental and clinical studies.
Carter SK
Cancer Chemother Rep 2; 1974 Mar; 4(1):3-11. PubMed ID: 4826498
[No Abstract] [Full Text] [Related]
2. Statistical designs for experiments in combination therapy.
Miller I
Cancer Chemother Rep 2; 1974 Mar; 4(1):151-6. PubMed ID: 4826494
[No Abstract] [Full Text] [Related]
3. Experimental models and their clinical correlations.
Carter SK; Goldin A
Natl Cancer Inst Monogr; 1977 Mar; (45):63-74. PubMed ID: 927496
[No Abstract] [Full Text] [Related]
4. Combination chemotherapy: considerations for design and analysis.
Lloyd HH
Cancer Chemother Rep 2; 1974 Mar; 4(1):157-65. PubMed ID: 4826495
[No Abstract] [Full Text] [Related]
5. The use of drugs in combination for the treatment of cancer: rationale and results.
DeVita VT; Schein PS
N Engl J Med; 1973 May; 288(19):998-1006. PubMed ID: 4348752
[No Abstract] [Full Text] [Related]
6. [Models and methods used for the selection of antitumor preparations in the USSR and abroad].
Sof'ina ZP
Vopr Onkol; 1976; 22(4):82-96. PubMed ID: 1274284
[No Abstract] [Full Text] [Related]
7. Clinical development of anticancer agents--a National Cancer Institute perspective.
Marsoni S; Wittes R
Cancer Treat Rep; 1984 Jan; 68(1):77-85. PubMed ID: 6362870
[No Abstract] [Full Text] [Related]
8. Collection and presentation of combination data.
Mancher RR
Cancer Chemother Rep 2; 1974 Mar; 4(1):167-80. PubMed ID: 4826496
[No Abstract] [Full Text] [Related]
9. Enhancement of antitumor effectiveness of ICRF-159 (NSC-129943) against early L1210 leukemia by combination with cis-diamminedichloroplatinum (NSC-119875) or daunomycin (NSC-82151).
Woodman RJ
Cancer Chemother Rep 2; 1974 Mar; 4(1):45-52. PubMed ID: 4826499
[No Abstract] [Full Text] [Related]
10. Rationale of combination chemotherapy based on preclinical experiments.
Goldin A
Cancer Chemother Rep 3; 1973 Mar; 4(2):189-98. PubMed ID: 4580857
[No Abstract] [Full Text] [Related]
11. NCI launches an innovative design for a breast cancer clinical trial.
Whitworth A
J Natl Cancer Inst; 2006 Sep; 98(17):1178-9. PubMed ID: 16954467
[No Abstract] [Full Text] [Related]
12. Modified protocol for the testing of new synthetics in the L1210 lymphoid leukemia murine model in the DR&D program, DCT, NCI.
Geran RI; Greenberg NH; Macdonald MM; Abbott BJ
Natl Cancer Inst Monogr; 1977 Mar; (45):151-3. PubMed ID: 927490
[No Abstract] [Full Text] [Related]
13. Body burden of cancer in relationship to therapeutic outcome: consideration of preclinical evidence.
Griswold DP
Cancer Treat Rep; 1986 Jan; 70(1):81-6. PubMed ID: 3943116
[No Abstract] [Full Text] [Related]
14. Report of the Cancer Chemotherapy Collaborative Program Review Committee: the Richardson report. June 1966, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
Cancer Treat Rep; 1984 Jan; 68(1):343-56. PubMed ID: 6692435
[No Abstract] [Full Text] [Related]
15. [Oxaliplatin: perspectives and future developments].
Marty M; Cottu PH; Lerebours F; Bedairia N; Hocini H; Espié M
Bull Cancer; 2001 Aug; 88 Spec No():S5-8. PubMed ID: 11567907
[No Abstract] [Full Text] [Related]
16. Alternation of chemotherapy and radiotherapy in cancer management. I. Summary of the Division of Cancer Treatment Workshop.
Looney WB; Goldie JH; Little JB; Hopkins HA; Read EJ; Wittes R
Cancer Treat Rep; 1985; 69(7-8):769-75. PubMed ID: 4016787
[No Abstract] [Full Text] [Related]
17. Some thoughts on experimental models and their clinical correlations.
Carter SK
Eur J Cancer (1965); 1973; 9(11-12):833-41. PubMed ID: 4804310
[No Abstract] [Full Text] [Related]
18. Screening at the National Cancer Institute.
Goldin A; Venditti JM; Carter SK
Natl Cancer Inst Monogr; 1977 Mar; (45):37-48. PubMed ID: 337155
[No Abstract] [Full Text] [Related]
19. NIH Consensus Development Conference summary: Adjuvant Chemotherapy of Breast Cancer.
J Tenn Med Assoc; 1981 Mar; 74(3):190-2. PubMed ID: 7024644
[No Abstract] [Full Text] [Related]
20. Adjuvant chemotherapy of breast cancer. Sponsored by the National Cancer Institute, assisted by the Office for Medical Applications of Research, NIH.
Conn Med; 1980 Nov; 44(11):721-3. PubMed ID: 7226778
[No Abstract] [Full Text] [Related]
[Next] [New Search]
